An Analysis of High-Risk Human Papillomavirus DNA-Negative Cervical Precancers in the ASCUS-LSIL Triage Study (ALTS)-Reference-Cited by-同舟云学术

An Analysis of High-Risk Human Papillomavirus DNA-Negative Cervical Precancers in the ASCUS-LSIL Triage Study (ALTS)

Published:2008-04 Issue:4 Volume:111 Page:847-856
ISSN:0029-7844
Container-title:Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Castle Philip E.,Cox J Thomas,Jeronimo Jose,Solomon Diane,Wheeler Cosette M.,Gravitt Patti E.,Schiffman Mark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference31 articles.

1. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus.;Obstet Gynecol,2005

2. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.;Wright;Am J Obstet Gynecol,2007

3. American Cancer Society guideline for the early detection of cervical neoplasia and cancer.;Saslow;CA Cancer J Clin,2002

4. Chapter 10: New dimensions in cervical cancer screening.;Cuzick;Vaccine,2006

5. Adding a test for human papillomavirus DNA to cervical-cancer screening.;Wright;N Engl J Med,2003

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus–positive and -Negative Cervical Precancers;Cancer Prevention Research;2020-07-12

2. HR-HPV E6/E7 mRNA In Situ Hybridization;American Journal of Surgical Pathology;2017-05

3. Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women;Papillomavirus Research;2016-12

4. Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial;BMC Cancer;2015-12

5. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type;PLOS ONE;2015-06-17